Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood (Q44261276)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood |
scientific article |
Statements
1 reference
Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood (English)
1 reference
Marion Macey
1 reference
Desmond McCarthy
1 reference
Urooj Azam
1 reference
Timothy Milne
1 reference
Peter Golledge
1 reference
Adrian Newland
1 reference
1 January 2003
1 reference
1 reference
51
1 reference
1
1 reference
30-40
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference